Found 14 matching trials
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma PHASE2 This is a prospective, Two-arm, comparative, randomized, controlled phase I...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis PHASE2 To evaluate the safety and efficacy of sintilimab combined with regorafenib...
Show More Location
Multiple Locations
Learn More & Join Trial
HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC PHASE2 This study is a single-arm Phase II clinical trial aiming to evaluate the s...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced Cholangiocarcinoma PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of h...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome PHASE2 Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure NA This study is a prospective, randomized controlled, multicenter clinical st...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens PHASE2 Liver metastasis is the main reason that affects the survival rates of pati...
Show More Location
the first affiliated hospital, Sun-Yat sen university
Learn More & Join Trial
cTACE or DEB-TACE+HAIC Combined With Regorafenib ยฑ Anti-PD1 Antibody for uHCC N/A explore the effectiveness and safety of conventional transarterial chemoemb...
Show More Location
Multiple Locations
Learn More & Join Trial